Colossal Biosciences
Highly Engaged Employees
Highly Engaged EmployeesBusiness Services · Texas, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
1401 Lavaca St Unit 155, Austin, Texas, ...Website
www.colossal.comRevenue
$27.5 MillionIndustry
ZI Rank: 2
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
3
2
4
1
1
2
About Colossal Biosciences
Colossal Biosciences is a biotechnology company pioneering the field of de-extinction, using advanced genetic engineering and CRISPR technologies to revive extinct species such as the woolly mammoth. The company combines genomics, synthetic biology, and conservation science to develop solutions aimed at biodiversity restoration and ecosystem health. In addition to de-extinction, Colossal builds genomic tools and technologies that can support conservation efforts, prevent species extinction, and advance biological research.Explore more
Colossal Biosciences Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Colossal Biosciences your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Colossal Biosciences recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Colossal Biosciences has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Colossal Biosciences launches new products
Check out if Colossal Biosciences is spiking on competitors!
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Colossal Biosciences
Colossal Biosciences, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Colossal Biosciences has new funding data
Click to see if Colossal Biosciences had a recent Job posting/layoffs
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Colossal Biosciences
Compare insights from companies similar to Colossal Biosciences, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Colossal Biosciences is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Colossal Biosciences is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Colossal Biosciences.
Colossal Biosciences financials insights
Gather financial insights about Colossal Biosciences, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Angel/Seed
$15M
2022
Series A
$75M
Other Financing Round
$10M
2023
Series B
$150M
2025
Series C
$320M
Colossal Biosciences Tech Stack
A closer look at the technologies used by Colossal Biosciences
Most Recent Scoops
Person-Based
Research & Development
Person-Based
Hiring Plans
Colossal Biosciences has more open roles in Engineering & Technical than it has had at any time in the past 9 months. Areas of expertise include: Biology, Assay Development, Molecular Biology, Fluorescent Microscopy, Cross-Functional Collaboration, Cell Biology, and Scientific Studies.
Hiring Plans
Person-Based
Person-Based
Research & Development, Bioengineering
Colossal Biosciences News & Media
Colossal Foundation and University of Tasmania Partner to Combat Devil Facial Tumour Disease with Vaccines and Gene Editing
The collaboration leverages Colossal's marsupial de-extinction and conservation biotechnology platform to save the Tasmanian devil from a contagious cancer that has driven 80% population declines across Tasmania DALLAS and HOBART, Australia, June 30, 2026 /PRNewswire/ -- The Colossal...Colossal Biosciences and U.S. Fish and Wildlife Service Launch Landmark BioVault Initiative for Every ESA-Listed Species
Partnership will harness biobanking and genomic technologies to strengthen species recovery and biodiversity conservation. DALLAS, June 25, 2026 /PRNewswire/ -- Colossal Biosciences, the world's first de-extinction company, and the Department of Interior today announced a landmark...Colossal Bioscience’s Multidisciplinary Science Approach Makes Major Breakthrough: Artificial Avian Eggs
Colossal founder Ben Lamm explains the company's scientific efforts to restore extinct bird species.Colossal Biosciences Hatches First Chicks from Its Fully Artificial Egg System
The first-ever shell-less incubation system to support complete avian embryo development, enabling next-generation conservation and de-extinction DALLAS, May 19, 2026 /PRNewswire/ -- Colossal Biosciences, the world's first de-extinction company, today announced that it has hatched live...
Read more news
Top Business Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Colossal Biosciences
Sign Up For FreeTo access detailed company insights
Colossal Biosciences is a biotechnology company pioneering the field of de-extinction, using advanced genetic engineering and CRISPR technologies to revive extinct species such as the woolly mammoth. The company combines genomics, synthetic biology, and conservation science to develop solutions aimed at biodiversity restoration and ecosystem health... Read More
